Alaa Halawa

Director at Alloy Therapeutics.

Raised on Alloy Therapeutics filings

$30M

of $40M offered across 1 Form D filing

Form D filings: 1
Teammates: 9
Last filing: Apr 15, 2026

Company

Alloy Therapeutics

Biotech · Waltham, MA

Transgenic mice for human antibody discovery

Transgenic mice for human antibody discovery

Investors: 11
Still open: $10M

Investors: 11
Sector: Biotech
HQ: Waltham, MA

Alloy Therapeutics filings

Alloy Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Apr 15, 2026	Equity	$30M/ $40M	Form D

EquityFiled Apr 15, 2026Form D
$30M/ $40M

Works with

Also named on Alloy Therapeutics filings

Errik B. AndersonPresident, Form D signerForm D signer Christian KanadyDirector Alex KolicichDirector Anthony SunDirector Jason CammDirector Jason ColomaDirector Logan SnyderDirector Piotr BobrowiczExecutive Officer, Director Ulrik NielsenDirector